DB
CORZ

Dmitry Balyasny’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

Dmitry Balyasny’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-13,442
Closed -$20K – 3413
2022
Q2 		$20K Buy
+13,442
New +$61.8K ﹤0.01% 2492
2021
Q4 		– Sell
-150,000
Closed -$1.52M – 2716
2021
Q3 		$1.52M Hold
150,000
– – 0.01% 1206
2021
Q2 		$1.48M Buy
+150,000
New +$1.48M 0.01% 1118

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
JWM
JGP Wealth Management Bend, Oregon $1.11B AUM 35.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Dmitry Balyasny's CORZ Position: Q3 2022 in Review

Dmitry Balyasny sold out of Core Scientific, Inc. Common Stock (CORZ) in Q3 2022, closing a stake of 13,442 shares — an estimated $20K sold.

Dmitry Balyasny first reported a position in CORZ in Q2 2021 and held it in 3 quarters. The position peaked at $1.52M in Q3 2021. 137 funds tracked by Wall St. Rank hold CORZ as of Q3 2022.

  • Dmitry Balyasny reported no remaining Core Scientific, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Dmitry Balyasny sold 13,442 Core Scientific, Inc. Common Stock shares in Q3 2022, an estimated $20K.
  • Dmitry Balyasny first reported a position in Core Scientific, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
  • Dmitry Balyasny's Core Scientific, Inc. Common Stock position peaked at $1.52M in Q3 2021.
  • 137 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q3 2022.

Based on Balyasny Asset Management's 13F filing for Q3 2022, filed 15 Nov 2022.